Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis
Azuri J, Hammerman A, Aboalhasan E, Sluckis B, Arbel R. Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis. Diabetes Obes Metab. 2023 Apr;25(4):961-964. doi: 10.1111/dom.14940. Epub 2022 Dec 27. PMID: 36507900. Highlights: Tirzepatide was compared to Semaglutide to analyze the cost and value of […]